NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 222 filers reported holding NOVOCURE LTD in Q4 2023. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $17,615,312 | +22.4% | 1,028,331 | +11.6% | 0.17% | +28.9% |
Q1 2024 | $14,397,039 | +21.5% | 921,116 | +16.1% | 0.14% | +12.5% |
Q4 2023 | $11,846,561 | +72.8% | 793,474 | +86.9% | 0.12% | +60.0% |
Q3 2023 | $6,854,658 | -15.9% | 424,437 | +116.0% | 0.08% | -3.8% |
Q2 2023 | $8,154,543 | -57.8% | 196,495 | -38.8% | 0.08% | -61.0% |
Q1 2023 | $19,303,196 | -23.1% | 320,971 | -6.2% | 0.20% | -26.7% |
Q4 2022 | $25,101,104 | -5.7% | 342,210 | -2.3% | 0.27% | -12.5% |
Q3 2022 | $26,614,000 | +7.8% | 350,271 | -1.4% | 0.31% | +9.9% |
Q2 2022 | $24,687,000 | -40.9% | 355,214 | -29.6% | 0.28% | -24.9% |
Q1 2022 | $41,786,000 | +28.4% | 504,354 | +16.4% | 0.38% | +47.1% |
Q4 2021 | $32,531,000 | +23.5% | 433,284 | +91.1% | 0.26% | +24.2% |
Q3 2021 | $26,344,000 | -66.9% | 226,767 | -36.9% | 0.21% | -64.6% |
Q2 2021 | $79,692,000 | +20653.1% | 359,266 | +12279.9% | 0.58% | +19366.7% |
Q1 2021 | $384,000 | -97.7% | 2,902 | -98.1% | 0.00% | -97.9% |
Q3 2020 | $16,735,000 | +1229.2% | 150,350 | +608.3% | 0.15% | +1227.3% |
Q2 2020 | $1,259,000 | -89.1% | 21,227 | -87.6% | 0.01% | -91.5% |
Q1 2020 | $11,533,000 | +250.4% | 171,258 | +338.5% | 0.13% | +441.7% |
Q4 2019 | $3,291,000 | -13.7% | 39,056 | -23.4% | 0.02% | -20.0% |
Q3 2019 | $3,813,000 | -85.2% | 50,995 | -87.5% | 0.03% | -84.5% |
Q2 2019 | $25,724,000 | +45.9% | 406,833 | +11.2% | 0.19% | +55.2% |
Q1 2019 | $17,631,000 | +52.3% | 366,010 | +5.9% | 0.12% | +34.4% |
Q4 2018 | $11,575,000 | +116.9% | 345,726 | +239.5% | 0.09% | +173.5% |
Q3 2018 | $5,336,000 | -52.1% | 101,823 | -71.4% | 0.03% | -57.0% |
Q2 2018 | $11,142,000 | -53.9% | 355,967 | -67.9% | 0.08% | -55.1% |
Q1 2018 | $24,152,000 | +10.5% | 1,107,899 | +2.4% | 0.18% | +10.0% |
Q4 2017 | $21,854,000 | +32.1% | 1,081,898 | +29.8% | 0.16% | +34.5% |
Q3 2017 | $16,546,000 | +15.6% | 833,576 | +0.8% | 0.12% | +14.4% |
Q2 2017 | $14,308,000 | – | 827,054 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |